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32 The Journal of Thoracic and Cardioackground: Endovascular treatment of thoracic aortic diseases demonstrated low
erioperative morbidity and mortality when compared with conventional open
epair. Long-term effectiveness of this minimally invasive technique remains to be
roven. The Talent Thoracic Retrospective Registry was designed to evaluate the
mpact of this therapy on patients treated in 7 major European referral centers over
n 8-year period.
ethods: Data from 457 consecutive patients (113 emergency and 344 elective
ases) who underwent endovascular thoracic aortic repair with the Medtronic Talent
horacic stent graft (Medtronic/AVE, Santa Rosa, Calif) were collected. Follow-up
nalysis (24  19.4 months, range 1-85.1 months) was based on clinical and
maging findings, including all adverse events. To ensure consistency of data
nterpretation and event reporting, one physician reviewed all adverse events and
eaths for the whole cohort of patients. In the case of discrepancies, the treating
hysicians were queried.
indings: Among 422 patients who survived the interventional procedure (in-
ospital mortality 5%, 23 patients), mortality during follow-up was 8.5% (36
atients), and in 11 of them the death was related to the aortic disease. Persistent
ndoleak was reported at imaging follow-up in 64 cases: 44 were primary (9.6%)
nd 21 occurred during follow-up (4.9%). Seven patients with persistent endoleak
ad aortic rupture during follow-up, at a variable time from 40 days to 35 months,
nd all subsequently died. A minor incidence of migration of the stent graft (7
ases), graft fabric alteration (2 cases), and modular disconnection (3 cases) was
bserved at imaging. Kaplan-Meier overall survival estimate at 1 year was 90.97%,
t 3 years was 85.36%, and at 5 years was 77.49%. At the same intervals, freedom
rom a second procedure (either open conversion or endovascular) was 92.45%,
1.3%, and 70.0%, respectively.
onclusion: Endovascular treatment for thoracic aortic disease with the Talent stent
raft is associated with low early morbidity and mortality rates also for patients who
re at high risk and treated on an emergency basis. Follow-up data indicate a
ubstantial durability of the procedure with a high freedom from related death and
econdary interventions.
he natural history of degenerative thoracic aortic disease is progressive and
may lead to dilation, dissection, and rupture. Aggressive medical treatment
and careful imaging follow-up contributed to improve survival of patients
ith thoracic aortic diseases. However, medical therapy alone can only delay, but
ot avoid, aneurysm expansion and rupture: reported 5-year mortality is 16% for
neurysms smaller than 6 cm in diameter and 31% for aneurysms larger than 6 cm
vascular Surgery ● August 2006
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ETn diameter.1-3 Therefore, preventive surgical resection h
ong been considered the only treatment strategy, although
ssociated with significant mortality and morbidity.4-9
The advent of endovascular techniques revolutionized
he management of thoracic aortic disease, enabling low-
nvasive repair even in high-risk patients unfit for open
urgery. Compared with open surgery, stent-graft treatment
s associated with decreased perioperative mortality rates
nd fewer complications, even in older patients with signif-
cant comorbidities.10-23 However, data on midterm an
ong-term follow-up are limited. The Talent Thoracic Ret-
ospective Registry (TTR) was designed to collect outcome
ata from patients who underwent endoluminal treatment
ith the Medtronic Talent thoracic stent graft (Medtronic/
VE, Santa Rosa, Calif) in 7 European referral centers. Data
ollection was focused on clinical and imaging follow-up
ith particular reference to mortality and long-term com-
lications.
ethods
nrolment
he entire cohort study consisted of 457 consecutive patients who
nderwent endovascular thoracic aortic repair with the Talent
horacic stent graft between November 1996 and March 2004.
even European referral centers (Bologna, Toulouse, Rostock, Lille,
ienna, Nieuwegein, and Marseille) provided data from patients
reated consecutively, with a minimum of 1-month follow-up. The
thical committee of each institute approved the study. Baseline
emographic and clinical characteristics are listed in Tabl
ncluding information on comorbidities, American Society of
nesthesiologists (ASA) class, previous cardiac or aortic surgery,
neurysm/dissection anatomy, and operative and postoperative
ourses. Follow-up analysis was formed on clinical and imaging
ndings until the last visit date, including all adverse events.
ostoperative imaging findings were focused to any evidence of
xpansion of aneurysm size or graft-related problems, such as
inking, migration, modular disconnection, or integrity of the graft
abric. Data were collected on case report forms and entered in two
eparate databases by a data collection specialist and by the lead
uthor (R.F.; Maastricht, The Netherlands, and Bologna, Italy).
ase report forms were all reviewed by the lead author and
hecked for inconsistencies. In case of discrepancies, the partici-
ating investigator at each site was queried to ensure appropriate
nterpretation of events. The two different databases were then
ompared and errors in data entries were corrected by checking on
Abbreviations and Acronyms
ASA American Society of Anesthesiologists
CI  confidence interval
CT  computed tomography
MRImagnetic resonance imaging
OR  odds ratio
TTR Talent Thoracic Retrospective Registryhe specific case report form. r
The Journal of Thoracicatient Characteristics
he registry comprises 350 male and 107 female patients with a
ean age of 59.6 years, ranging from 19 to 91 years (Table 
pectrum of thoracic aortic diseases comprised 180 (39.4%) tho-
acic aortic dissections, 137 (29.9%) atherosclerotic aneurysms, 14
3%) pseudoaneurysms, 29 (6.3%) penetrating ulcers, 12 (2.6%)
ntramural hematomas, and 85 (18%) posttraumatic aneurysms
Table 1). Two hundred fifty-six (56%) patients were classifie
SA class III/IV/V. Previous cardiac or aortic surgery was re-
orted on 21 (4.6%) and 103 (22.5%) patients, respectively, while
(1.1%) patients had already received endovascular therapy for
bdominal aortic aneurysm. Mean aortic diameter for the aortic
issection and atherosclerotic aneurysms was 60.1  16.7 (range:
6-136 mm) (Table 2).
maging Evaluation
efore treatment all patients were examined by at least one tomo-
raphic imaging modality, such as computed tomography (CT) and
agnetic resonance imaging (MRI), in addition to angiography or
ransesophageal echocardiography. Information on maximum an-
urysm diameter or on dissection size, proximal and distal ana-
omic extension, and distance from the left subclavian artery were
ABLE 1. Demographics and clinical characteristics of
atients (n  457)
No. %
ale 350 76.6
ge, y (mean  SD) 59.6  16
SA class (III) 256 56
revious aortic surgery 103 22.5
revious cardiac surgery 21 4.6
ypertension 331 72.4
enal insufficiency 72 15.7
OPD 102 22.3
iabetes 48 10.5
VA 33 7.2
arfan syndrome 15 3.2
moking 110 24.1
ortic disease (total)
Degenerative aneurysm 137 29.9
Dissection 180 39.4
Posttraumatic aneurysm 85 18.6
Pseudoaneurysm 14 3.1
Penetrating ulcer 29 6.3
Intramural hematoma 12 2.6
ortic disease (acute) 113 24.7
Degenerative aneurysm 18
Dissection 37
Posttraumatic aneurysm 41
Pseudoaneurysm 4
Penetrating ulcer 8
Intramural hematoma 5
D, Standard deviation; ASA, American Society of Anesthesiologists;
OPD, chronic obstructive pulmonary disease; CVA, cerebral vascular
ccident.ecorded. CT scan alone (33%) or in association with angiography
and Cardiovascular Surgery ● Volume 132, Number 2 333
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ET 22%) or angiography combined with MRI (15%) was the most
requently used imaging method. Imaging follow-up was assessed
ccording to the set protocol of each center, generally consisting of
0 days to 6 months and yearly CT or MRI: CT was performed in
5% and MRI in 21% of cases. A chest x-ray film was also
btained in 21% of patients. Information regarding aneurysm
xpansion or reduction in size, endoleak, aneurysm sac/false lu-
en thrombosis, and stent-graft material alteration were collected.
evice Description
he Talent Thoracic stent graft is composed of a Dacron graft
aterial supported by self-expanding nitinol springs. The springs
re sewn to the graft material with polyester sutures. The graft
aterial is a sheet of monofilament polyester with a seam joining
he edges to create a cylindrical tube. Opposite the seam is the
onnecting bar, which attaches the most proximal and distal
prings. The connecting bar provides columnar strength to the
evice and facilitates deployment. During implantation, the con-
ecting bar should be oriented to the outer radius for stent-graft
onformability and kink resistance. All nitinol components are
ABLE 2. Procedural details and early results (457 patients)
No. %
eneral anesthesia 453 99.1
aximum diameter (dissection and
atherosclerotic aneurysms),
mm (mean  SD)
307
60.1 16.7
ength of covered aorta, mm (mean  SD) 131.5  44.1
tent-graft segment used
One 312 68.3
Two 94 20.6
Three 35 7.6
More than three 5 1.1
escending aorta proximal (distance from
the LSA  1 cm)
124 27.1
cclusion of the LSA 54 11.8
With previous revascularization 22
Without previous revascularization 32
n-hospital mortality 23 5.1
Emergency 9/113 7.9
Elective 14/344 4.1
rocedure technical failure
Impossibility of stent insertion or
deployment
10 2.2
Conversion to surgery 10 2.2
Persistent endoleak 44 9.6
n-hospital complications 58 12.7
Stroke 17 3.7
Paraplegia 8 1.7
Vascular local 15 3.3
Extension of dissection 5 1.1
Cardiac 7 1.5
Pulmonary 2 0.4
Renal 4 0.8
D, Standard deviation; LSA, left subclavian artery.urface treated to enhance long-term fatigue performance. The T
34 The Journal of Thoracic and Cardiovascular Surgery ● Augualent stent graft system has many modular sections that can be
sed to treat a wide variety of thoracic lesions. The stent graft has
hree proximal and distal configurations. The proximal configura-
ions are FreeFlo, Bare Spring (22 mm only), and Open Web,
hich all have a flared geometry. The FreeFlo design (different
rom the Bare Spring configuration) has a bare spring and a
ini-support spring, which improves sealing for sizes 24 to 46
m. The distal configurations are Bare Spring, Closed Web, and
pen Web. The Open Web configuration was designed for use as
istal extensions for the Talent stent-graft system.
nterventional Endovascular Procedure
eneral anesthesia was used for the endovascular aortic procedure
n 453 of 457 patients. One hundred thirteen (27.4%) patients were
reated under emergency conditions and 344 (75.3%) patients were
reated electively. The mean length of covered aorta was 131.5
m, ranging from 28 to 380 mm with one stent used in 70% of
ases. The stent graft was positioned in the proximal descending
ortic segment in 124 patients (neck length 1 cm). In 54 patients
he stent graft was positioned in the distal aortic arch with cover-
ge of the left subclavian artery to extend the proximal landing
one. In 40.7% of them (22 patients) revascularization of the left
ubclavian artery was performed before stent-graft treatment.
tatistical Analysis
ncidence rates of events are reported by giving the number of
atients experiencing the event followed by the corresponding
ercentage. Continuous data are reported by giving the mean 
tandard deviation and/or median and the range of values ob-
erved. Where incidence rates (or proportions) were statistically
ompared between groups, the 2 test or Fisher exact test was
sed. Stepwise logistic regression analysis was performed to de-
ermine predictors of in-hospital death and in-hospital complica-
ions (stroke, paraplegia, extension of dissection, vascular local,
enal, cardiac, pulmonary). Noncorrelated variables with P  .05
t univariate analyses were included in the multivariate models;
odel precision was evaluated by the Hosmer-Lemeshow goodness-
f-fit statistic. Estimates of times to events and the accompanying
urves were generated by the method of Kaplan and Meier. Sta-
istical analyses were carried out with SPSS software package
ersion 13.0 (SPSS, Inc, Chicago, Ill).
esults
rocedural Technical Failure
echnical failure, for example, failure to complete an
ntended stent-graft deployment, occurred in 10 (2.2%)
atients owing to inadequate caliber of the femoral or
liac artery (failure of graft insertion, 7 cases) or difficult
eployment (3 cases). Immediate conversion to open repair
as documented in 3 (0.7%) cases. Perioperative endoleak
as visualized at the end of the procedure in 98 patients
Table 3). However, 26 endoleaks sealed spontaneou
uring follow-up, whereas an adjunctive endovascular treat-
ent with insertion of a graft extension allowed endoleak
esolution in 18. Ten cases of primary endoleak leading to
neurysm expansion were converted to open surgical repair.
herefore, the rate of persistent primary endoleak was 9.6%
st 2006
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ET44 patients). Endoleak type I was the most common
7.7%), whereas the incidence of type III (0.7%) and type II
1.5%) was very low.
n-hospital Mortality
he length of hospital stay was 12.8 days (range 1-149) with a
edian of 9 days. Twenty-three patients died, an in-hospital
within 30 days of the procedure or within the same hospital-
zation as the primary procedure) mortality of 7.9% for acute
nd 4% for elective cases (P .16). Two of 23 (0.4%) patients
ied during the endovascular procedure of aortic rupture; both
ere emergency cases of type B aortic dissection. Multivariate
ogistic regression analysis showed that age of 75 years or
lder (odds ratio [OR] 2.49; 95% confidence interval [CI]
.02-6.43; P .048) and ASA class IV or V (OR 3.0; 95% CI
.20-7.47; P  .018) were independent predictors of in-hos-
ital mortality (94.3% of correct classification, Hosmer-Leme-
how goodness-of-fit P  .770) (Table 3). Traumatic aor
njury could not be used in this model because there were no
n-hospital deaths in the modeled trauma population. Univar-
ABLE 3. Predictors of in-hospital death and in-hospital
omplications (logistic regression analysis*)
Univariate
analysis P
Multivariate
analysis
OR (95% CI) P
n-hospital death
ASA class (IV) .01 3.00 (1.20-7.47) .018
Experience (2000 y) .09
Age (75 y) .03 2.49 (1.02-6.43) .048
Male .88
Patient status (acute) .11
Traumatic aortic injury .03
Aortic aneurysm .16
Dissection .66
Penetrating ulcer and
haematoma
.43
Relevant surgical history .65
Marfan .98
Persistent endoleak .21
Occluded subclavian artery .60
Reintervention .41
n-hospital complications
ASA class (IV) .0001 2.27 (1.16-4.44) .016
Experience (2000 y) .014
Age (75 y) .007
Male .12
Patient status (acute) .0001 2.79 (1.48-5.24) .001
Traumatic aortic injury .05 0.32 (0.12-0.81) .016
Occluded subclavian artery .51
R, Odds ratio; CI, confidence interval; ASA, American Society of
nesthesiologists. *Only variables with P  .05 at the univariate analysis
ere entered into the multivariate analysis.ate analysis showed that traumatic aortic injury had a statisti- m
The Journal of Thoracically significantly lower risk of in-hospital death than other
tiologies (P  .03) (Table 3).
n-hospital Complications
ajor adverse events are listed in Table 2. The most 
on were cerebral vascular accidents and vascular trauma
uring the procedure. Multivariate logistic regression
nalysis showed that acute status (OR 2.8; 95% CI 1.5-5.2;
 .001) and ASA class IV or V (OR 2.3; 95% CI 1.2-4.4;
 .016) were independent predictors of in-hospital com-
lications, whereas traumatic aortic injury was signifi-
antly associated to lower rate of complications (OR 0.3;
5% CI 0.1-0.8; P .016) (86.3% of correct classification,
osmer-Lemeshow goodness-of-fit P  .711) (Table 3)
troke occurred in 17 patients and was significantly asso-
iated to occlusion of the left subclavian artery without
revious revascularization (P  .004, Fisher exact test).
araplegia (3 patients) and paraparesis (5 patients) occurred
n 8 cases (4 degenerative aneurysm and 4 type B dissec-
ion) and was significantly associated to length of covered
orta greater than 20 cm (P  .001, Fisher exact text). At
ollow-up, the spinal ischemic damage was persistent in the
cases of paraplegia, whereas paraparesis resolved com-
letely in 4 of 5 patients.
ortality and Aortic Rupture at Follow-up
linical and imaging mean follow-up was 24  19.4
ABLE 4. Follow-up data (422 patients)
No. %
ortality
Overall 36 8.5
Death related to aneurysm/dissection 11 2.6
ailure of procedure
Aortic rupture 7 1.6
Conversion to surgery 3 0.7
Persistent secondary endoleak 21 4.9
tent-graft complications
Migration 7 1.6
Modular disconnection 6 1.4
Graft integrity not maintained 2 0.4
neurysm/false lumen thrombosis
Total 305 72.3
Partial 80 18.9
Absent 18 4.3
Not reported 9 2.1
hange in aneurysm dimension
Increase 72 17.1
Decrease 165 39.1
No change 50 11.8
Not reported 135 32
ength of follow-up, months (mean standard deviation 24 19.4, median
9.5, range 1-85.1).onths (Table 4). Ninety-five of 422 patients had more than
and Cardiovascular Surgery ● Volume 132, Number 2 335
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ETyears of clinical and imaging follow-up available, includ-
ng 23 with over 5 years of follow-up. Late mortality was
.5% (36 patients), and in 11 of them death was related to
he aorta: 7 cases of aortic rupture at a variable time from 40
ays to 35 months, 2 extentions of dissection, and 2 aortoe-
ophageal fistulas (Figure 1). Other cause of death incl
yocardial infarction, respiratory insufficiency, cerebrovas-
ular accident, and neoplasm. In 5 patients the cause of
eath was not specified in the case report form. All 7
atients who had an aortic rupture during follow-up subse-
uently died. Among them, 6 had aortic dissection as pri-
ary disease and all 7 patients had type I persistent primary
r secondary endoleak, with aneurysm expansion at imag-
ng follow-up (Figure 2).
econdary Endoleak
econdary endoleak (types I and III) was reported in 44
10.4%) patients. Endovascular adjunctive treatment al-
igure 1. In-hospital and follow-up mortality (overall death and
eath related to stent-graft procedure).
igure 2. Early and long-term rate of aortic rupture in patients
yith and without endoleak (log-rank test P < .0001).
36 The Journal of Thoracic and Cardiovascular Surgery ● Auguowed successful sealing in 19 of these patients; one case of
pontaneous resolution was recorded, while in 3 additional
atients conversion to open repair was necessary (Figure
wenty-one (4.9%) patients did not undergo treatment for
econdary endoleak.
tent-graft Complications
igration (reported as millimeters of distance of the prox-
mal covered part of the stent graft from the left subclavian
rtery both at the implant and during follow-up) greater than
mm was observed in 7 patients (median 10 mm, range
-40 mm). A type I endoleak was present in 2 of them.
isconnection among stent-graft segments was visualized at
maging follow-up in 6 patients, leading to secondary en-
oleak type III in 4 patients.
Alteration of the graft material was identified in 2 pa-
ients. One patient had an aortoesophageal fistula 2 years
fter successful endovascular treatment of an atherosclerotic
neurysm. On CT scan, a detachment of the distal nitinol
rame was noted, facing the esophageal erosion. Another
ase of proximal detachment of one nitinol frame had no
linical consequences.
hange in Aneurysm Dimension
he dynamics of aneurysm dimension are summarized in
able 4. Thirteen of 22 patients with endoleak ty
among patients in which this information was reported),
ither primary or secondary, showed an increase of the
neurysm sac (medium 9 mm, ranging from 5 to 80 mm).
ong-term Survival
aplan-Meier overall survival estimate at 1 year was 90.1%, at
years was 84.6%, and at 5 years was 74.1%. Kaplan-Meier
stimate for freedom from related death was 96.0% at 1
igure 3. Freedom from second procedure (defined as conversion
o surgery or second endovascular treatment) in hospital and
uring follow-up.ear, 93.9% at 3 years, and 90.2% at 5 years. At the same
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ETnterval, freedom from a second procedure (either open
onversion or endovascular) was 92.4%, 81.3%, and 70.0%,
espectively (Figure 3).
iscussion
ndovascular treatment of descending thoracic aortic dis-
ases is a recent advance among interventional techniques,
eceiving increasing attention as a nonsurgical alternative to
pen repair. More notably than in abdominal aortic aneu-
ysm, in which endovascular techniques compare with a
ower risk surgery, stent-graft repair for thoracic aortic
iseases is able to offer a therapeutic option even to high-
isk patients unfit for open surgery. The feasibility of endo-
ascular treatment in thoracic aortic diseases was first re-
orted by Dake and associates10 in 1994, using a homema
itinol-Dacron stent graft in 103 patients. In 1997, commer-
ially manufactured stent grafts enabled increasing use and
rowth of technical skill and knowledge in many cen-
ers.11-20 Experience with endovascular treatment in a w
pectrum of aortic diseases demonstrates the feasibility of this
pproach even in unstable patients with encouraging early
nd midterm results.21-23 However, long-term follow-up o
he first thoracic homemade device is discouraging24 and
ssociated with low survival. Accordingly, experience with
ndovascular treatment of abdominal aortic diseases25,26
timulated the need for long-term outcome data and efficacy
f the stent graft in aortic diseases. The present experience
as some limitations: Data were retrospectively collected,
ith no control over the inclusion criteria for the endovas-
ular procedure. The lack of a randomized or concurrent
ontrol patient group precluded direct comparison with con-
entional open surgical repair. In addition, the absence of
utopsy confirmation in deceased patients does not allow in
ll cases exclusion of aortic rupture as a possible cause of
eath.
Yet, this is the first study on long-term results in a wide
ohort of patients (457) over an 8-year period, with more
han 3 years of clinical and imaging follow-up available in
5 patients. Early results are comparable with other reported
ase series: in-hospital mortality was 5%, comprising 113
atients treated under emergency condition. An advantage
f endovascular repair in acute aortic syndrome is its
otential to reduce blood loss27,28 with respect to ope
urgery, in which back-bleeding from branch arteries and
nastomotic sites or from iatrogenic venous injuries could
recipitate shock and neurologic consequences. Most peri-
perative complications in emergency endovascular cases
f this study arose from preexisting medical conditions and
ere not procedure related. This study showed that in pa-
ients with traumatic aortic rupture (85 patients with no mor-
ality), endovascular stent-graft treatment strongly abated
he high mortality of conventional open surgical repair.29 In
atients with complex multiple trauma, the possibility of a
The Journal of Thoracicow-invasive treatment of the aortic lesion may allow a
rompt management of the other associated lesions, with
imited impact on trauma destabilization and improved
verall survival. The feasibility of endovascular treatment
n patients with Marfan syndrome is controversial, because
f the particular fragility of the aortic wall. No significant
ifferences in results and outcome emerged from data anal-
sis of the 15 Marfan patients with type B dissection in-
luded in this registry. However, no definite results could be
rawn from such a limited number of cases.
The present study showed that the most frequent com-
lications in endovascular procedure are stroke (3.7%) and
ascular lesions at the access site (3.2%), both probably
elated to the difficult advancement and manipulation of the
heath, which still has a large outer diameter (22F-27F) and
elative inflexibility. New developments of stent-graft ma-
erial and design might reduce these problems. Among
everal variables examined, the only significant predictor of
troke was the occlusion of the left subclavian artery with-
ut previous revascularization. With regard to intentional
eft subclavian artery occlusion the available data are con-
icting; although recent endovascular reports30 suggest a
elative safety if some precautions are met, surgical expe-
ience with deliberate ligation of the vertebral artery31 leads
o a 5.4% rate of ischemic complications.
Spinal cord ischemia with resultant paraplegia is of sig-
ificant concern with open surgery of descending thoracic
ortic aneurysms,32 while the endovascular stent graft ho
he potential for reducing the risk, avoiding crossclamping,
ignificant blood loss, and severe hypotension. However,
xperience with endovascular treatment does not allow us to
dentify the anatomic and clinical characteristics for spinal
ord ischemia. Concomitant or previous abdominal aneu-
ysm repair has been reported as a risk factor.26,33 In our
egistry, paraplegia occurred in only 3 patients and it oc-
urred in patients without previous abdominal aortic sur-
ery. Long-segment thoracic aortic exclusion was the most
mportant predictor of spinal ischemia, both for patients
ith dissection and for those with aneurysm.
Long-term survival is one of the major concerns in
atients with severe comorbidities: 56% of this population
ad an ASA class of III or more. In this cohort of high-risk
atients, Kaplan-Meier curves at 36 months indicate a sur-
ival of 84.6% (Figure 1), with a low incidence of 
elated deaths (9%) and secondary procedures, both surgical
nd interventional (11%). Long-term results confirm that
ndoleak is the most important risk for aortic rupture. All
atients with aortic rupture during the follow-up had type I
ersistent endoleak. According to the literature,34-37 type II
ndoleak, due to reperfusion of the aneurysm sac by inter-
ostal arteries, is relatively uncommon (0.5% primary and
.8% secondary endoleak) and does not seem to constitute
risk factor for aortic rupture. Migration has not been
and Cardiovascular Surgery ● Volume 132, Number 2 337
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ETnvestigated previously in thoracic endografting.38,39 In-
eed, all previous case series and registries have a maxi-
um of 1-year follow-up or a limited number of patients for
onger periods. However, migration seems uncommon in
his setting, even several years after implant. In the present
eries, migration was assessed by reporting differences in
he distance of the proximal covered part of the stent graft
rom the left subclavian artery between the postoperative
nd subsequent imaging; it occurred in only 7 patients.
lthough the cases are few, migration was potentially
aused by inadequate oversizing or disease progression
roximally or distally, resulting in slow enlargement of the
anding zones and subsequent loss of fixation. A major
oncern in endovascular treatment is the durability of the
raft material, especially in the case of young patients.
abric deterioration has been reported with almost all de-
ices in abdominal series and also with thoracic stent grafts.
ith first-generation endovascular grafts using wire-formed
itinol, electrochemical corrosion leading to stent fracture
as been reported, even after a short period of implanta-
ion.24 Nitinol possesses a high elasticity and very g
iocompatibility, and it is known to have good resistance to
orrosion, depending on the processing techniques and the
uality of the protective titanium oxide surface layer. Im-
rovements in the manufacturing process have led to better
uality material and improved the surface finish. Laser
utting, polishing, and heat treatment procedures have en-
anced nitinol’s corrosion resistance. Our data seem to
onfirm the durability of the material, with 2 cases in a
ohort of 422 patients, some of whom have the stent graft in
itu for more than 8 years.
In conclusion, endovascular treatment for thoracic aortic
isease with the Talent stent graft carried out at high-
olume referral centers is associated with low early mor-
idity and mortality rates also for patients at high risk and
reated on an emergency basis. Follow-up data indicate a
ubstantial durability of the procedure with a high freedom
rom related death and secondary interventions. Long-term
urveillance will be crucial to discover complications unique
o thoracic endovascular interventions and to determine
hich patients are appropriate candidates for stent-graft
herapy.
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